source
- Novo Nordisk secures biotech partner for Parkinson's cell therapy as GSK signs hepatitis B drug deal in ChinaNovo Nordisk has found a biotech partner to advance its early‑stage Parkinson's disease cell therapy, giving the program a new development home. GSK disclosed a commercial agreement to sell its he…
- Experts highlight growing role of treatment intensification for metastatic castration-sensitive prostate cancerDuring an OncLive Peer Exchange, prostate-cancer specialists examined how treatment intensification is reshaping management of metastatic castration-sensitive prostate cancer. They noted that andr…